Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | MRK | REGN |
|---|
| Close | 149.52 | 927.89 |
| Market Cap | $371B | $93.4B |
| 1M | +2.90% | +22.37% |
| P/E (TTM) | 117.2 | 19.5 |
| Forward P/E | 19.6 | 13.4 |
| P/E 5-Yr Percentile | 81 | 56 |
| P/S | 5.6 | 5.4 |
| P/B | 8.9 | 2.7 |
| Dividend Yield | 2.87% | 0.45% |
| Latest Quarter Revenue | $16.6B | $5.1B |
| Revenue YoY | +5.1% | +36.3% |
| Gross Margin | 73.5% | — |
| Latest Quarter EPS | -0.54 | 18.45 |
| Avg Post-Earnings Move | ±1.7% | ±1.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.37% | 3.66% |
| 90-Day Net Insider Buying | −$30.0M | −$6.5M |
MRK · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
